DARPA Seeks a Few Good Microarrays To Meet Challenges of Biodefense | GenomeWeb

What’s a handshake worth? If it’s a handshake with one of the program managers of the Defense Advanced Research Projects Agency (DARPA), it might be worth millions of dollars in funding.

To be sure, millions of federal tax dollars won’t necessarily flow into a microarray commercialization project based on one conversation, but it’s a way to begin the funding process, said Alan Rudolph, program manager in DARPA’s defense sciences office.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.